Home > Financial Ratios > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
AKUMS DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

AKUMS DRUGS & PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 12.981.551.08-3.900.10

What is the latest EV/Core EBITDA ratio of AKUMS DRUGS & PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of AKUMS DRUGS & PHARMACEUTICALS is 12.98 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202512.98
Mar20241.55
Mar20231.08
Mar2022-3.90
Mar20210.10

How is EV/Core EBITDA of AKUMS DRUGS & PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 12.98
737.42
Mar2024 1.55
43.52
Mar2023 1.08
Positive
Mar2022 -3.9
Negative
Mar2021 0.1 -

Other Financial Ratios of AKUMS DRUGS & PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of AKUMS DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS ₹8,254.8 Cr 7.4% 4.7% 14.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS

7.4%

4.7%

14.9%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses